Lumexa Imaging's Dr. Kemp Joins RSNA Board
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2h ago
0mins
Source: PRnewswire
- Leadership Change: Dr. Jennifer L. Kemp, Chair of Lumexa Imaging's Center for Quality, has been elected to the Board of Directors of the Radiological Society of North America, reflecting the company's clinical leadership and the vital role of physicians in radiology.
- Patient Experience Enhancement: In her role as Chief of Patient Experience at Scanslated, Dr. Kemp leads initiatives to improve patient understanding of radiology results, showcasing the company's commitment to innovation in patient engagement.
- Technology Platform Utilization: Lumexa Imaging has utilized Scanslated's AI-driven software to provide over 2 million patients with clear radiology reports, significantly enhancing their likelihood of choosing Lumexa Imaging centers in the future.
- Industry Development Commitment: Dr. Kemp's role at RSNA will help guide the future of radiology, ensuring high-quality patient care while strengthening the voice of radiologists, aligning with Lumexa Imaging's commitment to clinical excellence and patient experience.
Analyst Views on LMRI
Wall Street analysts forecast LMRI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LMRI is 22.71 USD with a low forecast of 22.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
8 Buy
0 Hold
0 Sell
Strong Buy
Current: 13.830
Low
22.00
Averages
22.71
High
23.00
Current: 13.830
Low
22.00
Averages
22.71
High
23.00
About LMRI
Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services. The Company offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The Company and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.








